Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial

Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil, Michael R. Sperling, Martin Johnson, Sarah Lu
Format: Artigo
Jezik:engleski
Izdano: 2013
Online pristup:https://doi.org/10.1111/epi.12433
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!